ReviewJournal of experimental & clinical cancer research : CR2024

GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy.

M Caforio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.